buserelin has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezoe, K; Kato, K; Kobayashi, T; Murata, N; Yabuuchi, A | 1 |
| Chin, KY; Ima-Nirwana, S; Mohamad, NV | 1 |
| Chin, KY; Mohamad, NV; Soelaiman, IN | 1 |
| Bonn, P; Ekblad, E; Ohlsson, B; Roth, B; Sand, E; Weström, B | 1 |
| Ekblad, E; Jönsson, A; Ohlsson, B; Sand, E | 1 |
| Makita, S; Oshima, K; Suzuki, K; Yoshida, Y | 1 |
| Akhtar, FB; Marshall, GR; Nieschlag, E; Wickings, EJ | 1 |
| Gold, E; Goulding, A | 1 |
| Furuya, K; Hirata, J; Ishikawa, N; Kikuchi, Y; Makimura, N; Mitsui, C; Mizumoto, Y; Nagata, I; Tokuoka, S | 1 |
| Aoki, D; Futamura, Y; Katsuki, Y; Nozawa, S; Shibutani, Y; Takano, Y; Udagawa, Y | 1 |
| Feng, W; Gold, E; Goulding, A | 1 |
| Kalu, DN | 1 |
1 review(s) available for buserelin and Disease Models, Animal
| Article | Year |
|---|---|
The ovariectomized rat model of postmenopausal bone loss.
Topics: Aging; Animals; Buserelin; Disease Models, Animal; Female; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Rats | 1991 |
11 other study(ies) available for buserelin and Disease Models, Animal
| Article | Year |
|---|---|
Evaluation of uterine receptivity after gonadotropin releasing hormone agonist administration as an oocyte maturation trigger: a rodent model.
Topics: Animals; Buserelin; Chorionic Gonadotropin; Disease Models, Animal; Drug Evaluation, Preclinical; Embryo Implantation; Embryo Transfer; Endometrium; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Male; Mice; Mice, Inbred ICR; Oocytes; Oogenesis; Ovary; Pregnancy; Pregnancy Rate; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Uterus | 2019 |
Effect of tocotrienol from
Topics: Animals; Bixaceae; Bone and Bones; Buserelin; Calcium; Carotenoids; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Molecular Structure; Osteoporosis; Plant Extracts; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tocotrienols | 2018 |
Effects of tocotrienol from Bixa orellana (annatto) on bone histomorphometry in a male osteoporosis model induced by buserelin.
Topics: Animals; Bixaceae; Bone Remodeling; Buserelin; Carotenoids; Disease Models, Animal; Fertility Agents, Female; Male; Osteoporosis; Plant Extracts; Rats; Rats, Sprague-Dawley; Sex Factors; Tocotrienols; Treatment Outcome | 2018 |
Structural and functional consequences of buserelin-induced enteric neuropathy in rat.
Topics: Animals; Buserelin; Colon; Disease Models, Animal; Estradiol; Feces; Female; Gastrointestinal Tract; Gastrointestinal Transit; Ileum; Intestinal Pseudo-Obstruction; Lipids; Neurons; Rats, Sprague-Dawley; Stomach; Uterus | 2014 |
Long‑term follow‑up of buserelin‑induced enteric neuropathy in rats.
Topics: Animals; Buserelin; Colon; Disease Models, Animal; Eosinophils; Female; Follow-Up Studies; Ileum; Injections, Subcutaneous; Intestinal Pseudo-Obstruction; Mast Cells; Neurons; Rats; Rats, Sprague-Dawley; Stomach; T-Lymphocytes; Time Factors | 2016 |
Treatment with buserelin, an agonist of gonadotropin-releasing hormone, suppresses ovarian hyperstimulation syndrome induced in rabbits.
Topics: Animals; Ascites; Buserelin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Menotropins; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Progesterone; Rabbits; Uterus | 2004 |
Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps.
Topics: Animals; Buserelin; Disease Models, Animal; Ejaculation; Gonadotropin-Releasing Hormone; Infusions, Parenteral; Luteinizing Hormone; Macaca mulatta; Male; Oligospermia; Testosterone | 1983 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |
[The effect of danazol and buserelin on natural killer activity in experimental endometriosis of the rat].
Topics: Animals; Buserelin; Cells, Cultured; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Female; Killer Cells, Natural; Rats; Rats, Wistar; Spleen | 1995 |
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
Topics: Animals; Buserelin; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Immunity, Cellular; Interleukin-1; Killer Cells, Natural; Macrophages, Peritoneal; Nandrolone; Progesterone; Progesterone Congeners; Protein Kinase C; Rats; Rats, Sprague-Dawley | 1998 |
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus | 1992 |